文献速递心外重症与机械循环支持

经腋动脉微轴流左心室辅助装置植入后通路部位相关并发症

Complications related to the access site after transaxillary implantation of a microaxial left ventricular assist device.
PubMed 文献 · J Heart Lung Transplant · 2022-12-27

单中心回顾性分析2017年1月至2021年9月连续203例经腋动脉血管移植物植入Impella 5.0或5.5的成人患者,中位支持时间8天,随访中位232天;10.9%患者发生迟发型移植物感染,2.5%发生臂丛神经损伤。

要点

  • 203例经腋动脉植入Impella 5+患者中,13例(10.9%)发生迟发型移植物感染,中位发生时间86天。
  • 5例(2.5%)发生臂丛神经损伤导致神经功能障碍。
  • 保留血管移植物者中,完全取出移植物假体可能降低感染率但可能增加臂丛神经损伤风险,且该方法提供床旁拔除的可能。

核心结论

  • 10.9%的患者保留血管移植物后发生迟发型移植物感染。
  • 完全取出移植物假体可能降低感染率,但可能增加臂丛神经损伤风险;另一方面,该方法提供床旁拔除的可能性。

研究设计与样本

  • 单中心回顾性分析,纳入2017年1月至2021年9月连续203例成人患者,均经缝合于腋动脉的血管移植物植入Impella 5.0或5.5。

主要发现

  • 203例患者中,78例(38.4%)在临时机械循环支持期间死亡;55例(27.1%)成功脱离Impella 5+;70例(34.5%)桥接至耐久型左心室辅助装置,Impella 5+拔除后中位随访时间232天(IQR 68.5,597)。
  • 119例患者拔除Impella并缩短、结扎血管移植物后推至胸肌下;6例因早期移植物感染在拔除时完全取出移植物。
  • 13例(10.9%)在中位86天后发生迟发型移植物感染,需完全(n=10)或部分(n=2)取出保留的移植物;1例移植物感染经保守治疗成功。
  • 分析未发现移植物感染的特异性危险因素。
  • 203例中5例(2.5%)发生臂丛神经损伤导致神经功能障碍。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Impella 5.0 and 5.5 (summarized as Impella 5+) are microaxial, catheter-based left ventricular assist devices (LVAD) that are implanted via a vascular graft sutured to the axillary artery and provide blood flow of up to 5.5 liter/min. This study aims to investigate the incidence of long-term complications following circulatory support with Impella 5+. METHODS: A single-center retrospective analysis of 203 consecutive adult patients treated between January 2017 and September 2021 with a surgically implanted Impella 5.0 or 5.5 via a vascular graft sutured to the axillary artery. RESULTS: The median Impella support duration was 8 days. Of 203 patients, 78 (38.4%) died while on temporary mechanical circulatory support. Fifty-five (27.1%) were successfully weaned from Impella 5+ and 70 (34.5%) were bridged to a durable LVAD with a median follow-up time of 232 (IQR 68.5, 597) days after Impella 5+ explantation. In 119 of these patients, the Impella was explanted and the vascular graft was shortened, ligated, and pushed under the pectoralis muscle; in 6 patients early graft infection prompted complete graft removal during explantation. In addition, 13 patients (10.9%) developed a late-onset graft infection after a median of 86 days, requiring complete (n = 10) or partial (n = 2) explantation of the retained graft. In 1 patient, the graft infection was successfully treated by conservative therapy. Our analysis identified no specific risk factors for graft infections. Of the 203 patients, 5 (2.5%) developed a brachial plexus injury resulting in neurological dysfunction. CONCLUSIONS: In 10.9% of patients, retaining the vascular graft was complicated by a late graft infection. Complete explantation of the graft prosthesis may decrease the infection rate, but may in turn increase the risk of brachial plexus injury. On the other hand, this method offers the possibility of bedside explantation.

来源:J Heart Lung Transplant,查看原文。版权归原作者所有。

引用

  1. Lewin D, Nersesian G, Lanmüller P, et al. Complications related to the access site after transaxillary implantation of a microaxial left ventricular assist device. J Heart Lung Transplant. 2022. PMID: 36653272. doi:10.1016/j.healun.2022.12.018

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。